The administration of tissue plasminogen activator (tPA) in the first 90 min after a stroke reduces mortality, lowers the chances of symptomatic intracranial hemorrhage, and results in an earlier discharge time when compared to when tPA was administered within 181–270 min after stroke onset [7]. Here, PLAT is linked to intracranial hemorrhage.